US Stock MarketDetailed Quotes

Rani Therapeutics (RANI)

Watchlist
  • 1.096
  • +0.046+4.38%
Trading May 14 10:06 ET
109.39MMarket Cap-2.44P/E (TTM)

Rani Therapeutics (RANI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
47.28%-18.71M
103.40%294K
39.80%-5.06M
35.81%-5.8M
13.33%-8.15M
30.72%-35.5M
30.64%-8.66M
41.20%-8.41M
26.60%-9.03M
22.64%-9.4M
Net income from continuing operations
27.63%-40.95M
42.28%-9.07M
37.79%-7.91M
15.99%-11.22M
13.81%-12.74M
16.64%-56.58M
-11.86%-15.72M
30.60%-12.72M
28.41%-13.36M
12.20%-14.78M
Operating gains losses
1,043.08%743K
--591K
----
----
----
--65K
--0
----
----
----
Depreciation and amortization
-12.45%900K
-30.08%186K
-13.90%223K
-5.88%240K
1.21%251K
25.06%1.03M
17.18%266K
18.81%259K
34.92%255K
31.91%248K
Other non cash items
3.63%2.12M
-6.73%499K
-56.96%393K
338.22%688K
22.71%535K
60.33%2.04M
67.71%535K
187.11%913K
-50.63%157K
37.11%436K
Change In working capital
1,379.04%6.96M
627.74%5.97M
60.37%-260K
1,401.23%1.22M
-97.59%28K
74.58%-544K
62.14%-1.13M
24.07%-656K
-93.56%81K
155.04%1.16M
-Change in receivables
-277.10%-1.61M
-377.10%-2.04M
--0
--600K
---172K
---428K
---428K
--0
--0
--0
-Change in prepaid assets
-130.43%-192K
-464.83%-1.06M
105.52%46K
-30.03%473K
-30.46%347K
123.76%631K
-16.67%290K
9.94%-834K
24.26%676K
57.91%499K
-Change in payables and accrued expense
101.13%2.13M
1,141.46%1.02M
-72.52%119K
234.27%666K
-68.23%331K
193.48%1.06M
102.90%82K
34.89%433K
-150.82%-496K
161.15%1.04M
-Change in other current assets
----
----
----
----
----
--0
----
----
----
----
-Change in other current liabilities
-5.59%-1.91M
-1.47%-483K
44.80%-472K
-380.81%-476K
-26.46%-478K
-73.51%-1.81M
-81.68%-476K
-230.12%-855K
62.21%-99K
-45.95%-378K
-Change in other working capital
--8.54M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
47.28%-18.71M
103.40%294K
39.80%-5.06M
35.81%-5.8M
13.33%-8.15M
30.72%-35.5M
30.64%-8.66M
41.20%-8.41M
26.60%-9.03M
22.64%-9.4M
Investing cash flow
Cash flow from continuing investing activities
-135.49%-7.03M
-1,328.56%-30.97M
0
-12.44%5.71M
77.08%18.23M
-33.66%19.81M
-81.01%2.52M
-95.98%469K
727.00%6.53M
149.67%10.29M
Net PPE purchase and sale
67.16%-88K
--0
--0
60.64%-37K
-183.33%-51K
78.19%-268K
81.44%-31K
73.90%-125K
71.94%-94K
92.74%-18K
Net investment purchase and sale
-134.58%-6.94M
-1,313.64%-30.97M
--0
-13.13%5.75M
77.27%18.28M
-35.42%20.08M
-81.01%2.55M
-95.11%594K
488.88%6.62M
135.92%10.31M
Cash from discontinued investing activities
Investing cash flow
-135.49%-7.03M
-1,328.56%-30.97M
--0
-12.44%5.71M
77.08%18.23M
-33.66%19.81M
-81.01%2.52M
-95.98%469K
727.00%6.53M
149.67%10.29M
Financing cash flow
Cash flow from continuing financing activities
196.65%40.3M
698.22%44.85M
-113.10%-1.01M
33.33%188K
-3,183.47%-3.73M
5,730.47%13.59M
5,753.13%5.62M
15,622.45%7.7M
76.25%141K
1,412.50%121K
Net issuance payments of debt
-314.44%-20.72M
-152.59%-9.47M
-200.00%-3.75M
---3.75M
---3.75M
---5M
---3.75M
---1.25M
--0
--0
Net common stock issuance
188.02%52.6M
430.85%49.79M
----
----
----
--18.26M
--9.38M
----
----
----
Proceeds from stock option exercised by employees
2,192.43%8.48M
455,800.00%4.56M
-174.12%-63K
2,291.52%3.95M
-65.29%42K
-6.33%370K
-101.04%-1K
8.97%85K
85.39%165K
-8.33%121K
Net other financing activities
-25.53%-59K
-133.33%-21K
50.00%-7K
---8K
---23K
70.99%-47K
---9K
51.72%-14K
----
----
Cash from discontinued financing activities
Financing cash flow
196.65%40.3M
698.22%44.85M
-113.10%-1.01M
33.33%188K
-3,183.47%-3.73M
5,730.47%13.59M
5,753.13%5.62M
15,622.45%7.7M
76.25%141K
1,412.50%121K
Net cash flow
Beginning cash position
-33.03%4.26M
-2.78%4.64M
113.72%10.72M
43.84%10.61M
-33.03%4.26M
-76.86%6.36M
-12.70%4.78M
-37.73%5.01M
-62.14%7.38M
-76.86%6.36M
Current changes in cash
792.48%14.56M
2,852.23%14.17M
-2,462.03%-6.07M
104.44%105K
526.75%6.35M
90.06%-2.1M
-157.74%-515K
90.81%-237K
79.33%-2.36M
112.63%1.01M
End cash Position
341.53%18.82M
341.53%18.82M
-2.78%4.64M
113.72%10.72M
43.84%10.61M
-33.03%4.26M
-33.03%4.26M
-12.70%4.78M
-37.73%5.01M
-62.14%7.38M
Free cash flow
47.43%-18.8M
103.38%294K
40.68%-5.06M
36.06%-5.83M
12.95%-8.2M
31.83%-35.76M
31.31%-8.69M
42.26%-8.54M
27.80%-9.12M
24.04%-9.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 47.28%-18.71M103.40%294K39.80%-5.06M35.81%-5.8M13.33%-8.15M30.72%-35.5M30.64%-8.66M41.20%-8.41M26.60%-9.03M22.64%-9.4M
Net income from continuing operations 27.63%-40.95M42.28%-9.07M37.79%-7.91M15.99%-11.22M13.81%-12.74M16.64%-56.58M-11.86%-15.72M30.60%-12.72M28.41%-13.36M12.20%-14.78M
Operating gains losses 1,043.08%743K--591K--------------65K--0------------
Depreciation and amortization -12.45%900K-30.08%186K-13.90%223K-5.88%240K1.21%251K25.06%1.03M17.18%266K18.81%259K34.92%255K31.91%248K
Other non cash items 3.63%2.12M-6.73%499K-56.96%393K338.22%688K22.71%535K60.33%2.04M67.71%535K187.11%913K-50.63%157K37.11%436K
Change In working capital 1,379.04%6.96M627.74%5.97M60.37%-260K1,401.23%1.22M-97.59%28K74.58%-544K62.14%-1.13M24.07%-656K-93.56%81K155.04%1.16M
-Change in receivables -277.10%-1.61M-377.10%-2.04M--0--600K---172K---428K---428K--0--0--0
-Change in prepaid assets -130.43%-192K-464.83%-1.06M105.52%46K-30.03%473K-30.46%347K123.76%631K-16.67%290K9.94%-834K24.26%676K57.91%499K
-Change in payables and accrued expense 101.13%2.13M1,141.46%1.02M-72.52%119K234.27%666K-68.23%331K193.48%1.06M102.90%82K34.89%433K-150.82%-496K161.15%1.04M
-Change in other current assets ----------------------0----------------
-Change in other current liabilities -5.59%-1.91M-1.47%-483K44.80%-472K-380.81%-476K-26.46%-478K-73.51%-1.81M-81.68%-476K-230.12%-855K62.21%-99K-45.95%-378K
-Change in other working capital --8.54M------------------------------------
Cash from discontinued investing activities
Operating cash flow 47.28%-18.71M103.40%294K39.80%-5.06M35.81%-5.8M13.33%-8.15M30.72%-35.5M30.64%-8.66M41.20%-8.41M26.60%-9.03M22.64%-9.4M
Investing cash flow
Cash flow from continuing investing activities -135.49%-7.03M-1,328.56%-30.97M0-12.44%5.71M77.08%18.23M-33.66%19.81M-81.01%2.52M-95.98%469K727.00%6.53M149.67%10.29M
Net PPE purchase and sale 67.16%-88K--0--060.64%-37K-183.33%-51K78.19%-268K81.44%-31K73.90%-125K71.94%-94K92.74%-18K
Net investment purchase and sale -134.58%-6.94M-1,313.64%-30.97M--0-13.13%5.75M77.27%18.28M-35.42%20.08M-81.01%2.55M-95.11%594K488.88%6.62M135.92%10.31M
Cash from discontinued investing activities
Investing cash flow -135.49%-7.03M-1,328.56%-30.97M--0-12.44%5.71M77.08%18.23M-33.66%19.81M-81.01%2.52M-95.98%469K727.00%6.53M149.67%10.29M
Financing cash flow
Cash flow from continuing financing activities 196.65%40.3M698.22%44.85M-113.10%-1.01M33.33%188K-3,183.47%-3.73M5,730.47%13.59M5,753.13%5.62M15,622.45%7.7M76.25%141K1,412.50%121K
Net issuance payments of debt -314.44%-20.72M-152.59%-9.47M-200.00%-3.75M---3.75M---3.75M---5M---3.75M---1.25M--0--0
Net common stock issuance 188.02%52.6M430.85%49.79M--------------18.26M--9.38M------------
Proceeds from stock option exercised by employees 2,192.43%8.48M455,800.00%4.56M-174.12%-63K2,291.52%3.95M-65.29%42K-6.33%370K-101.04%-1K8.97%85K85.39%165K-8.33%121K
Net other financing activities -25.53%-59K-133.33%-21K50.00%-7K---8K---23K70.99%-47K---9K51.72%-14K--------
Cash from discontinued financing activities
Financing cash flow 196.65%40.3M698.22%44.85M-113.10%-1.01M33.33%188K-3,183.47%-3.73M5,730.47%13.59M5,753.13%5.62M15,622.45%7.7M76.25%141K1,412.50%121K
Net cash flow
Beginning cash position -33.03%4.26M-2.78%4.64M113.72%10.72M43.84%10.61M-33.03%4.26M-76.86%6.36M-12.70%4.78M-37.73%5.01M-62.14%7.38M-76.86%6.36M
Current changes in cash 792.48%14.56M2,852.23%14.17M-2,462.03%-6.07M104.44%105K526.75%6.35M90.06%-2.1M-157.74%-515K90.81%-237K79.33%-2.36M112.63%1.01M
End cash Position 341.53%18.82M341.53%18.82M-2.78%4.64M113.72%10.72M43.84%10.61M-33.03%4.26M-33.03%4.26M-12.70%4.78M-37.73%5.01M-62.14%7.38M
Free cash flow 47.43%-18.8M103.38%294K40.68%-5.06M36.06%-5.83M12.95%-8.2M31.83%-35.76M31.31%-8.69M42.26%-8.54M27.80%-9.12M24.04%-9.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More